Recent Finacing
Recent Raise
iHeart Japan develops iPS cell–derived multilayer cardiovascular constructs combining cardiac and vascular cells with gelatin hydrogel particles and is conducting a Phase I/II trial in dilated cardiomyopathy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
